SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form POS AM - Post-Effective amendments for registration statement:
SEC Accession No. 0001213900-16-010328
Filing Date
2016-01-22
Accepted
2016-01-22 08:12:31
Documents
15

Document Format Files

Seq Description Document Type Size
1 posam1_biondvax.htm POS AM 6442559
2 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM posam1ex23i_biondvax.htm EX-23.1 3598
3 GRAPHIC image001.jpg GRAPHIC 4730
4 GRAPHIC image002.jpg GRAPHIC 13073
5 GRAPHIC image003.jpg GRAPHIC 13060
6 GRAPHIC image004.jpg GRAPHIC 12958
7 GRAPHIC image005.jpg GRAPHIC 9194
8 GRAPHIC image006.jpg GRAPHIC 11794
9 GRAPHIC image007.jpg GRAPHIC 14520
10 GRAPHIC image008.jpg GRAPHIC 17650
11 GRAPHIC image009.jpg GRAPHIC 18417
12 GRAPHIC image010.jpg GRAPHIC 17552
13 GRAPHIC image011.jpg GRAPHIC 15973
14 GRAPHIC image012.jpg GRAPHIC 13610
15 GRAPHIC image013.jpg GRAPHIC 2063
  Complete submission text file 0001213900-16-010328.txt   6675560
Mailing Address 14 EINSTEIN ST. NES-ZIONA L3 74036
Business Address 14 EINSTEIN ST. NES-ZIONA L3 74036 972-8-9302529
BiondVax Pharmaceuticals Ltd. (Filer) CIK: 0001611747 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1213
Type: POS AM | Act: 33 | File No.: 333-201283 | Film No.: 161354734
SIC: 2836 Biological Products, (No Diagnostic Substances)